Zealand Pharma A/S | ZEAL - Cost Of Sales

Stock Price
280.30
Daily Change
0.60 0.21%
Monthly
-25.91%
Yearly
-50.30%
Q1 Forecast
254.31

Zealand Pharma A/S reported 410K in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Moderna USD 452M 245M Dec/2025
Organon & Co USD 745M 25M Sep/2025
Revvity USD 350.4M 26.05M Dec/2025
Tilray USD 164.37M 8.41M Sep/2025
Viatris USD 2.56B 167.3M Dec/2025
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025
Zealand Pharma A/S 410K 5K Jun/2025